These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39021227)

  • 1. Effect of Biliary Drainage on the Prognosis of Patients with Hepatocellular Carcinoma and Bile Duct Invasion.
    Yang K; Yang H; Kim CW; Nam HC; Kim JH; Lee A; Chang UI; Yang JM; Lee HL; Kwon JH; Nam SW; Lee SK; Sung PS; Han JW; Jang JW; Bae SH; Choi JY; Yoon SK; Kim HY
    Gut Liver; 2024 Sep; 18(5):877-887. PubMed ID: 39021227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEB-TACE versus cTACE for unresectable HCC with B1-type bile duct invasion after successful biliary drainage: A propensity score matching analysis.
    Fan W; Zheng X; Zhao X; Zhu B; Wu Y; Xue M; Tang R; Huang Z; Qiao L; Lu M; Tang Y; Wu J; Li J
    Cancer Med; 2024 Jul; 13(13):e7419. PubMed ID: 38970348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoembolisation for hepatocellular carcinoma with bile duct invasion: is preprocedural biliary drainage mandatory?
    Park J; Kim HC; Lee JH; Cho E; Kim M; Hur S; Jae HJ; Lee M; Chung JW
    Eur Radiol; 2018 Apr; 28(4):1540-1550. PubMed ID: 29124380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion.
    An J; Lee KS; Kim KM; Park DH; Lee SS; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
    Clin Mol Hepatol; 2017 Jun; 23(2):160-169. PubMed ID: 28506055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and predictive factors in cancer patients with obstructive jaundice treated by percutaneous transhepatic biliary drainage: A single-center experience.
    Sahinli H; Özet A
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S99-S103. PubMed ID: 33380661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective biliary drainage and proper treatment improve outcomes of hepatocellular carcinoma with obstructive jaundice.
    Suh YG; Kim DY; Han KH; Seong J
    Gut Liver; 2014 Sep; 8(5):526-35. PubMed ID: 25071072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Biliary Tract Invasion with Obstructive Jaundice on the Prognosis of Patients With Unresectable Hepatocellular Carcinoma.
    Jiang W; Fu X; Wang G; Qi H; Chen Z; Gao F
    Acad Radiol; 2023 Mar; 30(3):483-491. PubMed ID: 36150964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepato-biliary-enteric stent drainage as palliative treatment for proximal malignant obstructive jaundice.
    Pan H; Liang Z; Yin TS; Xie Y; Li DW
    Med Oncol; 2014 Mar; 31(3):853. PubMed ID: 24464214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma.
    Sugiyama G; Okabe Y; Ishida Y; Saitou F; Kawahara R; Ishikawa H; Horiuchi H; Kinoshita H; Tsuruta O; Sata M
    World J Gastroenterol; 2014 Jun; 20(22):6968-73. PubMed ID: 24944490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatectomy for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus, Including Cases with Obstructive Jaundice.
    Orimo T; Kamiyama T; Yokoo H; Wakayama K; Shimada S; Tsuruga Y; Kamachi H; Taketomi A
    Ann Surg Oncol; 2016 Aug; 23(8):2627-34. PubMed ID: 27006124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.
    Tanaka T; Kuzuya T; Ishigami M; Ito T; Ishizu Y; Honda T; Ishikawa T; Fujishiro M
    Oncology; 2020; 98(9):621-629. PubMed ID: 32434180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endoscopic biliary drainage in advanced hepatocellular carcinoma with jaundice.
    Woo HY; Han SY; Heo J; Kim DU; Baek DH; Yoo SY; Kim CW; Kim S; Song GA; Cho M; Kang DH
    PLoS One; 2017; 12(11):e0187469. PubMed ID: 29095941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative treatment of unresectable hepatocellular carcinoma with obstructive jaundice using biliary drainage with subsequent transarterial chemoembolization.
    Choi J; Ryu JK; Lee SH; Hwang JH; Ahn DW; Kim YT; Yoon YB; Yoon CJ; Kang SG; Chung JW
    J Palliat Med; 2013 Sep; 16(9):1026-33. PubMed ID: 23888306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy for bile duct invasion of hepatocellular carcinoma.
    Bahng S; Yoo BC; Paik SW; Koh KC; Lee KT; Lee JK; Lee JH; Choi MS; Lee KH
    Photochem Photobiol Sci; 2013 Mar; 12(3):439-45. PubMed ID: 23175171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute obstructive cholangitis after transarterial chemoembolization: the effect of percutaneous transhepatic removal of tumor fragment.
    Choi KH; Cho YK; An JK; Woo JJ; Kim HS; Choi YS
    Korean J Radiol; 2009; 10(2):197-201. PubMed ID: 19270868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are endoscopic or percutaneous biliary drainage effective for obstructive jaundice caused by hepatocellular carcinoma?
    Cho HC; Lee JK; Lee KH; Lee KT; Paik S; Choo SW; Do YS; Choo IW
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):224-31. PubMed ID: 21228705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obstructive jaundice secondary to ruptured hepatocellular carcinoma into the common bile duct. Surgical experiences of 20 cases.
    Chen MF; Jan YY; Jeng LB; Hwang TL; Wang CS; Chen SC
    Cancer; 1994 Mar; 73(5):1335-40. PubMed ID: 8111698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness, safety, and factors associated with the clinical success of endoscopic biliary drainage for patients with hepatocellular carcinoma: a retrospective multicenter study.
    Matsumi A; Kato H; Ueki T; Ishida E; Takatani M; Fujii M; Wato M; Toyokawa T; Harada R; Tsugeno H; Matsubara M; Matsushita H; Okada H
    BMC Gastroenterol; 2021 Jan; 21(1):28. PubMed ID: 33441096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score-Matched Study.
    Huang YH; Park BV; Chen YF; Gaba RC; Guzman G; Lokken RP
    J Vasc Interv Radiol; 2019 Sep; 30(9):1317-1324. PubMed ID: 31375450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.